πŸ‡ΊπŸ‡Έ FDA

Intelligence Β· INN Directory

Pharmaceutical Drugs

Regulatory status, brand names, and pipeline context for BD, medical affairs, and competitive intelligence teams.

Drugs indexed
4,797
Companies
1,769
Pipeline programs
20,548

Quick answer

NovaPharmaNews tracks 4,797 pharmaceutical drugs by INN (International Nonproprietary Name), with US FDA approval status, brand names, originators, routes of administration, and links to pipeline programs and patents. Search by generic name or browse A–Z for competitive intelligence and medical affairs reference.

Showing page 161 of 200 Β· A–Z by INN

  1. rocuronium bromide

    ROCURONIUM BROMIDE Teva Pharma GmbH

    INJECTION FDA: approved

  2. rofecoxib

    VIOXX

    ORAL FDA: approved

  3. roflumilast

    DAXAS Arcutis Biotherapeutics

    TOPICAL FDA: approved Β· EMA: approved

    R03DX07
  4. rolapitant

    VARUBY

    EMA: withdrawn

    A04AD
  5. rolapitant hydrochloride

    VARUBI

    ORAL FDA: approved

  6. romidepsin

    ISTODAX Teva Pharma GmbH

    INTRAVENOUS FDA: approved Β· EMA: refused Β· PMDA: approved

    L01XX39
  7. romiplostim

    NPLATE Amgen

    SUBCUTANEOUS FDA: approved Β· EMA: approved Β· TGA: approved Β· PMDA: approved Β· NMPA: clinical trials

    B02BX04
  8. romosozumab

    EVENITY Amgen

    EMA: approved Β· TGA: approved Β· PMDA: approved

    M05BX
  9. romosozumab-aqqg

    EVENITY

    INJECTION FDA: approved

  10. ropeginterferon

    NMPA: clinical trials

  11. ropeginterferon alfa-2b

    BESREMI

    EMA: approved

    L03AB15
  12. ropeginterferon alfa-2b-njft

    BESREMI Essential Pharma Limited

    SUBCUTANEOUS FDA: approved

  13. ropinirole hydrochloride

    ROPINIROLE HYDROCHLORIDE ELITE PHARMACEUTICALS INC /NV/

    ORAL FDA: approved

  14. ropivacaine

    NMPA: clinical trials

  15. ropivacaine hydrochloride

    ROPIVACAINE HYDROCHLORIDE Amneal Pharma Europe Ltd

    INJECTION FDA: approved

  16. rose bengal sodium i-131

    SODIUM ROSE BENGAL I 131

    INJECTION FDA: approved

  17. rosiglitazone

    AVANDAMET

    EMA: unknown

    A10BD03
  18. rosiglitazone maleate

    ROSIGLITAZONE MALEATE

    ORAL FDA: approved

  19. rosuvastatin

    APO-ROSUVASTATIN Alphapharm Pty Ltd

    TGA: approved Β· NMPA: clinical trials

  20. rosuvastatin calcium

    ROSUVASTATIN CALCIUM Amneal Pharma Europe Ltd

    ORAL FDA: approved

  21. rosuvastatin zinc

    ROSUVASTATIN ZINC

    ORAL FDA: approved

  22. rotateq

    NMPA: clinical trials

  23. rotavirus vaccine

    ROTASHIELD

    EMA: withdrawn

    J07BH
  24. rotavirus vaccine, live

    ROTARIX

    EMA: approved

    J07BH01

Frequently asked questions

What is the NovaPharmaNews drugs directory?

It is a searchable index of 4,797 pharmaceutical active ingredients and their marketed profiles β€” INN, brand names, US regulatory status, manufacturers, and cross-links to clinical pipeline and patent records.

Where does drug approval data come from?

Profiles combine FDA Drugs@FDA and Orange Book references, ClinicalTrials.gov pipeline links, and editorial enrichment. See our data sources page for attribution and update cadence. This directory is for professional reference, not medical advice.

How do I find a drug by brand name?

Use the search box on this page β€” it matches both INN (generic name) and slug. Brand names appear on each drug row and on the full drug profile page, with links to the originator company when available.

Data attribution and licensing: Data sources